ZEPP R&D Expense Growth
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares · R&D Expense Growth
ZEPP R&D Expense Growth
Latest reported-5.74%period ending
ZEPP FY R&D Growth (YoY) (0.00% → -5.74%)
Latest values, visible window
High-resolution chart · PNG
ZEPP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.7393% | |
| 554.9002% | |
| -33.0309% | |
| -3.7306% | |
| 2.4583% | |
| 25.0023% | |
| 49.2192% | |
| 83.5086% | |
| 14.325% | |
| 103.4217% | |
| 0% |